Data gathered: July 27
Alternative Data for Arcutis Biotherapeutics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | N/A | Sign up | Sign up | Sign up |
| Webpage traffic | N/A | Sign up | Sign up | Sign up |
| Employee Rating | N/A | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | N/A | Sign up | Sign up | Sign up |
| Facebook Followers | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | N/A | Sign up | Sign up | Sign up |
| Twitter Followers | N/A | Sign up | Sign up | Sign up |
| Twitter Mentions | N/A | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | N/A | Sign up | Sign up | Sign up |
About Arcutis Biotherapeutics
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
| Price | $10.07 |
| Target Price | Sign up |
| Volume | 1,460,000 |
| Market Cap | $1.17B |
| Year Range | $1.84 - $12.53 |
| Dividend Yield | 0% |
| Industry | Biotechnology |
In the news
Arcutis Biotherapeutics submits sNDA for ZORYVE foam to FDAJuly 22 - Thefly.com |
|
Arcutis Biotherapeutics (ARQT) Gets a Buy from TD CowenJuly 22 - TipRanks |
|
 |
Arcutis Biotherapeutics to host ZORYVE cream 0.15% KOL evenJuly 22 - Thefly.com |
 |
Mirae Asset Global Investments Co. Ltd. Purchases New Position in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)July 20 - ETF Daily News |
 |
Is Arcutis Biotherapeutics (ARQT) Stock Outpacing Its Medical Peers This Year?July 18 - Yahoo |
 |
Arcutis (ARQT) Stock Rises 31% in the Past Month: Here's WhyJuly 16 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '24 | 50M | 58M | -8.7M | -35M | -27M | -0.320 |
| Q4 '23 | 5.8M | 58M | -52M | -66M | -58M | -0.720 |
| Q3 '23 | 31M | 236M | -205M | -45M | 154M | -0.730 |
| Q2 '23 | 5.2M | 234M | -229M | -71M | 124M | -1.160 |
| Q1 '23 | 2.8M | 43M | -47M | -80M | -73M | -1.310 |
Insider Transactions View All
| Welgus Howard G. filed to sell 180,339 shares at $9.3. July 2 '24 |
| Welgus Howard G. filed to sell 176,658 shares at $8. June 6 '24 |
| Welgus Howard G. filed to sell 170,200 shares at $8. June 6 '24 |
| Burnett Patrick filed to sell 209,793 shares at $8.8. May 31 '24 |
| Burnett Patrick filed to sell 209,793 shares at $8.7. May 31 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Joshua Gottheimer Democrat |
Oct 15, 23 | Sell | $1K - $15K |
| Joshua Gottheimer Democrat |
May 19, 23 | Buy | $1K - $15K |
Read more about Arcutis Biotherapeutics (ARQT) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Arcutis Biotherapeutics?
The Market Cap of Arcutis Biotherapeutics is $1.17B.
What is the current stock price of Arcutis Biotherapeutics?
Currently, the price of one share of Arcutis Biotherapeutics stock is $10.07.
How can I analyze the ARQT stock price chart for investment decisions?
The ARQT stock price chart above provides a comprehensive visual representation of Arcutis Biotherapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Arcutis Biotherapeutics shares. Our platform offers an up-to-date ARQT stock price chart, along with technical data analysis and alternative data insights.
Does ARQT offer dividends to its shareholders?
As of our latest update, Arcutis Biotherapeutics (ARQT) does not offer dividends to its shareholders. Investors interested in Arcutis Biotherapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Arcutis Biotherapeutics?
Some of the similar stocks of Arcutis Biotherapeutics are .
.